CROTTI, LIA
 Distribuzione geografica
Continente #
NA - Nord America 3.043
EU - Europa 2.278
AS - Asia 1.506
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
AF - Africa 1
SA - Sud America 1
Totale 6.842
Nazione #
US - Stati Uniti d'America 2.990
CN - Cina 1.485
IE - Irlanda 797
UA - Ucraina 386
FI - Finlandia 294
IT - Italia 293
DE - Germania 235
SE - Svezia 92
GB - Regno Unito 89
CA - Canada 52
FR - Francia 39
BE - Belgio 26
IN - India 14
EU - Europa 6
RU - Federazione Russa 6
AU - Australia 5
IR - Iran 5
NL - Olanda 5
CH - Svizzera 3
DK - Danimarca 3
LU - Lussemburgo 3
ES - Italia 2
GR - Grecia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
HK - Hong Kong 1
IQ - Iraq 1
MU - Mauritius 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 6.842
Città #
Dublin 794
Chandler 708
Jacksonville 492
Nanjing 433
Ashburn 247
Nanchang 170
Beijing 159
Wilmington 145
Princeton 140
Lawrence 138
Shenyang 134
Hebei 119
Ann Arbor 118
Changsha 117
Jiaxing 108
Medford 97
Milan 83
Helsinki 82
Hangzhou 66
Tianjin 62
Boardman 47
Pavia 46
New York 42
Shanghai 40
Woodbridge 36
Toronto 32
Norwalk 27
Brussels 26
Verona 23
Fairfield 21
Seattle 21
Houston 18
Ottawa 17
Los Angeles 16
Kunming 15
Falls Church 14
Trieste 13
Bergamo 12
Des Moines 12
Pune 10
Berlin 8
Rochester 8
Jinan 7
Orange 7
Zhengzhou 7
Auburn Hills 6
Lodi 6
Travaco Siccomario 6
Dearborn 5
Guangzhou 5
Modena 5
Ningbo 5
Saint-herblain 5
San Francisco 5
Washington 5
Zola Predosa 5
Como 4
Dresden 4
Fuzhou 4
Saint Petersburg 4
Tappahannock 4
Van Nuys 4
Cork 3
Frankfurt am Main 3
Melbourne 3
Naples 3
Nuremberg 3
Nutley 3
Padova 3
Pontassieve 3
Saluzzo 3
Turin 3
Athens 2
Bologna 2
Borås 2
Brembate di Sopra 2
Cambridge 2
Catania 2
Changchun 2
Copenhagen 2
Esch-sur-Alzette 2
Falkenstein 2
Fiesole 2
Florence 2
Manchester 2
Oberhausen 2
Redmond 2
Redwood City 2
San Genesio Ed Uniti 2
Taizhou 2
Udine 2
Vercelli 2
Zanjan 2
Zurich 2
Amsterdam 1
Ardabil 1
Auckland 1
Baghdad 1
Bari 1
Bern 1
Totale 5.099
Nome #
Mapping the human genetic architecture of COVID-19 124
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 96
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 93
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 87
Gene symbol: KCNH2 83
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 82
A first update on mapping the human genetic architecture of COVID-19 79
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 77
FGF12 is a candidate Brugada syndrome locus. 77
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 77
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 75
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 74
The ICD for the long QT syndrome: which indications, complications, and results? 74
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 73
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 70
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 70
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 68
All LQT3 patients need an ICD. True or false? 66
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 65
Idiopathic Ventricular Fibrillation. 65
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 65
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 64
Cardiac sodium channel dysfunction in sudden infant death syndrome. 64
Inherited cardiac arrhythmia syndrome. Role of potassium channels 62
QT lungo, sindrome del 61
Cardiac potassium channel dysfunction in sudden infant death syndrome. 61
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 61
Prevalence of the congenital long-QT syndrome. 61
Gene symbol: SCN5A 60
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 60
Can a message from the dead save lives? 59
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 59
QTc behavior during exercise and genetic testing for the long-QT syndrome. 57
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 57
Ion channel diseases in children: manifestations and management. 57
Congenital long QT and short QT syndromes 57
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 56
Gene symbol: KCNH2. 56
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 56
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 56
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 55
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 55
Brugada and Long QT Syndrome are two different diseases: True or False? 55
Long QT syndrome-associated mutations in intrauterine fetal death. 55
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 55
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 54
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 54
The Long QT Syndrome 53
Gene expression and arrhythmic risk. 53
Gene symbol: KCNH2 53
Gene symbol: KCNH2. 52
Congenital long QT and short QT syndromes 52
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 52
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 52
Gene symbol: KCNQ1 52
Idiopathic Ventricular Fibrillation 51
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. 51
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 51
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 51
Sindrome di Brugada 50
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. 50
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 50
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 49
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 48
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 48
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 48
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 48
Gene symbol: KCNQ1. 48
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 48
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 48
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 48
Sudden cardiac death in infancy: Focus on prolonged repolarization 47
Gene symbol: KCNQ1. 47
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. 47
Gene symbol: KCNH2 47
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 47
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 47
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 47
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 46
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 46
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 46
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 46
Ion channels and beating heart: the players and the music 44
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 44
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 44
Molecular basis of atrial fibrillation 43
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 43
Congenital Short QT Syndrome 43
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 43
Long QT syndrome: from genetic basis to treatment 43
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 43
Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?" 43
Prevalence of long QT syndrome gene variants in sudden infant death syndrome. 42
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease ? 42
Gene symbol: SCN5A 42
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 42
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 42
Gene symbol: SCN5A. 42
The genetics underlying acquired long QT syndrome: impact for genetic screening. 42
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 42
Totale 5.635
Categoria #
all - tutte 23.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 6 6
2019/20201.767 507 732 8 79 3 85 9 97 13 113 117 4
2020/2021708 84 63 16 74 15 91 7 138 20 99 88 13
2021/2022577 13 5 33 7 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024717 92 136 22 53 73 196 23 77 5 30 10 0
Totale 7.004